Here at Safeguard Scientifics, we provide capital to growth-stage companies in both the life sciences and technology. It’s important to note, however, that Safeguard provides…
Posted by
We are constantly being reminded of the economic challenges impacting members of the European Union. It is no surprise that the economic upheaval in Greece…
Posted by
Global economic uncertainty, high unemployment, increased government regulation, and issues like healthcare reform are creating a lot of daunting headlines. Those issues are also being blamed…
Posted by
Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…
Posted by
PixelOptics’ emPower! eyewear is the world’s first and only electronic focusing eyeglasses—focusing faster than the blink of an eye. The technology is embedded inside the lenses and…
Posted by
The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…
Posted by
Ninety percent of migraine sufferers experience nausea, while 60 percent experience vomiting because of their migraine. As a result, today’s most common migraine treatments that…
Posted by
In America, there are more than 171 million dogs and cats in over 71 million households. Ninety-six percent of the drugs approved for these pets…
Posted by
According to a report published by Cambridge Associates LLC, private equity and venture capital funds in the U.S. continued to generate positive returns for their…
Posted by
